Phase 1/1b Study of TLC-6740 in Healthy Subjects and Subjects With Obesity, With or Without Diabetes

NCT05822544 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

564

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Subjects
Obesity
Type 2 Diabetes

Interventions

DRUG: TLC-6740 Oral Solution
OTHER: Placebo Oral Solution
DRUG: TLC-6740 Tablet
DRUG: Drug Metabolizing Enzyme
DRUG: Tirzepatide
OTHER: Placebo Tablet

Sponsor

OrsoBio, Inc